Mapping HIV-related behavioural surveillance among injecting drug users in Europe, 2008

Eurosurveillance

Volumn 16, Issue 36, 2011, Pages

  Hope, Vivian ^a   Jeannin, André ^b   Spencer, Brenda ^b   Gervasoni, Jean Pierre ^b   van de Laar, Marita ^h   Dubois Arber, Françoise ^b   Elford, Jonathan ^d   Lert, France ^e   Ward, Helen ^f   Low, Nicola ^g   Haour Knipe, Mary ⁱ   Pellaz, Marie Jeanne ^b   Graz, Bertrand ^b  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

^c EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

^d CITY UNIVERSITY   (United Kingdom)

^e INSERM   (France)

^f IMPERIAL COLLEGE LONDON   (United Kingdom)

^g UNIVERSITY OF BERN   (Switzerland)

^h ECDC   (Sweden)

ⁱ ECDC ^*

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DRUG USE; EPIDEMIC; EUROPE; HEALTH BEHAVIOR; HEALTH CARE ACCESS; HEALTH SURVEY; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; QUESTIONNAIRE; SEXUALLY TRANSMITTED DISEASE;

EID: 80052718453     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: 10.2807/ese.16.36.19960-en     Document Type: Article

References (24)

1. Wiessing L, Ncube F, Hedrich D, Griffiths P, Hope V, Gill N, et al. Surveillance of infectious diseases in IDUs across the EU: information from the EU expert network. Euro Surveill. 2004;8(4):pii=2368. Available from: http://www. eurosurveillance.org/ViewArticle.aspx?ArticleId=2368
2. Health Protection Agency, Health Protection Scotland, National Public Health Service for Wales, CDSC Northern Ireland, CRDHB. Shooting up: infections among injecting drug users in the United Kingdom 2008. London: Health Protection Agency; October 2009. Available from: http://www.hpa.org.uk/web/HPAwebFile/HPAweb_C/1254510653792
3. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Drug-related infectious diseases. Lisbon: EMCDDA. [Accessed 9 Jul 2010]. Available from: http://www.emcdda. europa.eu/themes/key-indicators/drid
4. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Trends in injecting drug use in Europe. Selected Issue 2010. Lisbon: EMCDDA: 2010. Available from: http://www.emcdda.europa.eu/publications/selected-issues/injecting
5. Hedrich D, Pirona A. Wiessing L. From margin to mainstream: the evolution of harm reduction responses to problem drug use in Europe. Drugs: Education, Prevention, and Policy. 2008;15(6):503-17. Available from: http://informahealthcare. com/doi/abs/10.1080/09687630802227673
6. Wodak A, Cooney A. Do needle syringe programs reduce HIV infection among injecting drug users: a comprehensive review of the international evidence. Subst Use Misuse. 2006;41(6-7):777-813.
7. World Health Organization (WHO). Effectiveness of sterile needle and syringe programming in reducing HIV/AIDS among injecting drug users. (Evidence for action technical papers). Geneva: WHO; 2004. Available from: http://www.who.int/hiv/pub/prev_care/effectivenesssterileneedle.pdf
8. Vickerman P, Hickman M, Judd A. Modelling the impact on hepatitis C transmission of reducing syringe sharing: London case study. Int J Epidemiol. 2007;36(2):396-405.
9. Van Den Berg C, Smit C, Van Brussel G, Coutinho R, Prins M; Amsterdam Cohort. Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users. Addiction. 2007;102(9):1454-62.
10. Hope VD, Hickman M, Ngui SL, Jones S, Telfer M, Bizzarri M, et al Measuring the incidence, prevalence and genetic relatedness of hepatitis C infections among a community recruited sample of injecting drug users, using dried blood spots. J Viral Hepat. 2011;18(4):262-70.
11. Des Jarlais DC, Dehne K, Casabona J. HIV surveillance among injecting drug users. AIDS. 2001;15 Supplement 3:S13-22.
12. Joint United Nations Programme on HIV/AIDS (UNAIDS), World Health Organization (WHO). UNAIDS/WHO Working Group on Global HIV/AIDS and STI Surveillance. Guidelines for second generation HIV surveillance. Geneva: UNAIDS and WHO; 2000. WHO/CDS/CSR/EDC/2000; UNAIDS/00.03E. Available from: http://data.unaids.org/publications/irc-pub01/jc370-2ndgeneration_en.pdf
13. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). An overview of the drug-related infectious diseases (DRID) key indicator. Lisbon: EMCDDA; 2009. Available from: http://www.emcdda.europa.eu/publications/methods/drid-overview
14. European Centre for the Epidemiological Monitoring of AIDS (EuroHIV). HIV/AIDS surveillance in Europe. Mid-year report 2001. No. 65. Saint-Maurice: Institut de Veille Sanitaire; 2001. Available from: http://www.ecdc.europa.eu/en/activities/surveillance/hiv/Documents/report_eurohiv_midyear_2001.pdf
15. European Centre for the Epidemiological Monitoring of AIDS (EuroHIV). EuroHIV 2006 survey on HIV and AIDS surveillance in the WHO European Region. Saint-Maurice: Institut de veille sanitaire; 2007. Available from: http://www.invs.sante.fr/publications/2007/eurohiv_2006/HIV_AIDS_Web.pdf
16. European Centre for Disease Prevention and Control. Mapping of HIV/STI behavioural surveillance in Europe. ECDC Technical Report. Stockholm: ECDC; September 2009. Available from: http://www.ecdc.europa.eu/en/publications/Publications/0909_TER_Mapping_of_HIV_STI_Behavioural_Surveillance_in_Europe.pdf
17. Dubois-Arber F, Jeannin A, Spencer B, Gervasoni JP, Graz B, Elford J, et al. Mapping HIV/STI behavioural surveillance in Europe. BMC Infect Dis. 2010;10:290.
18. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). An overview of the treatment demand key indicator (TDI). Lisbon: EMCDDA; 2009. Available from: http://www. emcdda.europa.eu/publications/methods/tdi-overview
19. Elford J, Jeannin A, Spencer B, Gervasoni JP, van de Laar MJ, Dubois-Arber F; et al. HIV and STI behavioural surveillance among men who have sex with men in Europe. Euro Surveill. 2009;14(47):pii=19414. Available from: http://www. eurosurveillance.org/ViewArticle.aspx?ArticleId=19414
20. Centre d'Estudis Epidemiològics sobre les Infeccions de Transmissió Sexual i Sida de Catalunya (CEEISCAT). SIVES 2008: integrated Aids/HIV/STI surveillance system of Catalonia (SIVES): biennial epidemiological report. Barcelona: Generalitat de Catalunya, Departament de Salut; 2008. (Technical document CEEISCAT, 19). Available from: http://www.ceescat.org/Documents_Ing1.htm
21. Vorobjov S, Uusküla A, Abel-Ollo K, Talu A, Rüütel K, Des Jarlais DC. Comparison of injecting drug users who obtain syringes from pharmacies and syringe exchange programs in Tallinn, Estonia. Harm Reduct J. 2009;6:3.
22. Hope VD, Judd A, Hickman M, Sutton A, Stimson GV, Parry JV, et al. HIV prevalence among injecting drug users in England and Wales 1990 to 2003: evidence for increased transmission in recent years. AIDS. 2005;19(11):1207-14.
23. Magnani R, Sabin K, Saidel T, Heckathorn D. Review of sampling hard-to-reach and hidden populations for HIV surveillance. AIDS. 2005;19 Suppl 2:S67-72.
24. World Health Organization (WHO). WHO, UNODC, UNAIDS technical guide for countries to set targets for universal access to HIV prevention, treatment and care for injecting drug users. Geneva: WHO; 2009. Available from: http://www.unodc.org/documents/hiv-aids/idu_target_setting_guide.pdf